{"name":"MiMedx Group, Inc.","slug":"mimedx-group-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Micronized dHACM","genericName":"Micronized dHACM","slug":"micronized-dhacm","indication":"Diabetic foot ulcers","status":"phase_3"}]}],"pipeline":[{"name":"Micronized dHACM","genericName":"Micronized dHACM","slug":"micronized-dhacm","phase":"phase_3","mechanism":"Micronized dehydrated human amnion/chorion membrane (dHACM) provides a biologic scaffold that promotes tissue regeneration and wound healing through growth factors and extracellular matrix components.","indications":["Diabetic foot ulcers","Chronic wounds","Surgical wounds"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxQVm8zMGd0cHY3Zk5BWEdDT1JIVlMtZ29fVTVPeFh4bC1CV3M0dGFsQlhOUGJ1dnM0NFUyX040R1hSSHp3TVBIeFhOUjc0aHRmektNTUZEQW1qNjk5TVg1NHZDMDBMWVRUWWl0N0JsT0gwZkg4bzZXLVJmYy1sSDZiMUUtUE5TOUJQc2JSX1pNVDRDeVNCMjR1bTIxLWJJNXRwV3ZWdkt6NUpWYWpHRGZDZWFsZ1hkUzE1bEhaVUFTSGFQYnFEOTdra3NOMnlWNE5GZzNDTEtTX1k2ZDEyZU00RkRQQjg5dF9iQUhISzdYVHotbjhYRUhoenVTQm5PNmh0?oc=5","date":"2026-02-24","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: MiMedx Group (MDXG), Ufp Technologies (UFPT) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: MiMedx Group (MDXG), Ufp Technologies (UFPT)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-09","type":"earnings","source":"simplywall.st","summary":"Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings - simplywall.st","headline":"Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNa05ldFBudXFmU1lCS05oSVRfWHAxTkFrZThyN3NxVUxsaGpwcU5kTEQ4ZmtYTEJLcHdTc2RscDZpWHpWRkZkay1nLWFwOVVkVkxyVkwwakZKeVVwaEZuSm5GZTliSXloQUFhMnVfMXJ2cFF6U25WVmpwOVQ2ejcxZw?oc=5","date":"2026-01-02","type":"trial","source":"Insightace Analytic","summary":"Regenerative Medicine Market Size and Revenue Impact Study 2025 to 2034 - Insightace Analytic","headline":"Regenerative Medicine Market Size and Revenue Impact Study 2025 to 2034","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-15","type":"pipeline","source":"simplywall.st","summary":"Is MiMedx Group, Inc.'s (NASDAQ:MDXG) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st","headline":"Is MiMedx Group, Inc.'s (NASDAQ:MDXG) Recent Stock Performance Tethered To Its Strong Fundamentals?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxPWEJPd0pZTlpmU3BqMXZqNWlYN0s1UjdqdElFeEIxaFI5ZkFpUGhPbE4tU2tVUFFmZHVYMmRSTk82ZjQxU3kwbzRfSFZiMEZMd2d5QlptaXEtazVsUVlZelp6R2xncFNWU0lRRlpmektRTjJFVWk0Zmw3YjRNWG1WVWo0X3R0UmZxYW96SUZsblN6LWN4VDVHV0N3XzZCR1FHZndCVUw4d2J0em1XN2tTQ2tyUFQtTTY4b0t2ai1YT2F3RFhLYnhkSVQxWFdNb3NZbUFmUUh0aWF0SDZJOHdmUWV0LTdXRVBqZHdBX0tkYWlMVjZFXzJYbFJCenFjVjc2VjlOQTBOV2R4ZVB5SUtrZFU0TkRYdzNZT0FrUy1aTWdZb2Nmc1VWSlhkWURTWF90d05CMGI5NEk0TE9DRXdUVHdWd2dobms?oc=5","date":"2025-11-24","type":"pipeline","source":"prnewswire.com","summary":"Regenerative Medicine Market to Skyrocket to USD 403.86 Billion by 2032 Driven by Cell & Gene Therapy Breakthroughs, Stem Cell Advancements, and Multi-Indication Expansion - prnewswire.com","headline":"Regenerative Medicine Market to Skyrocket to USD 403.86 Billion by 2032 Driven by Cell & Gene Therapy Breakthroughs, Ste","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-13","type":"pipeline","source":"simplywall.st","summary":"Chief Commercial Officer Of MiMedx Group Sold 71% Of Their Shares - simplywall.st","headline":"Chief Commercial Officer Of MiMedx Group Sold 71% Of Their Shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPOHQzTUE0OUlXVUZabHhIQ0ZIMGNjcGdBOFU4TFJJUks4MmdsOWVZaDNxNFBpbFNHajNjM21valcyN3VxMmw1UG1YRnRMLUZGa0dQVWVKTmFaQ2JlOEdRMWo0TWFhcUlzZFA5dDdxbDVWT2dVLWxmU1hUTjVxWGlIR3VVQnJqWVZ1WFE?oc=5","date":"2025-10-20","type":"pipeline","source":"Los Angeles Business Journal","summary":"Biotech Firm Turn Therapeutics Goes Public - Los Angeles Business Journal","headline":"Biotech Firm Turn Therapeutics Goes Public","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE0tWU1OdU0ySlpQRlVTbEwxS1RnWFV1UG9KcHpldnFINGlwUlhCWFY0T2xPOFJOQVVvS1lLVl9ta3BteVVldU5hcy12bWJqdHJiNVJJ?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"MDXG Stock Price, News & Analysis - Stock Titan","headline":"MDXG Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5IRjkxaXpLRTJEdml5RTFJQnBUZWNaa2xpWU91WUhXbExQYnBlM2NUNmhyTG5QRS1FbXA5OEVmUi1jOGVpdGRmU0xadWdCdTlmSmxGV1g0ZUFoY2JZTDFUOHVzYTc1TU9C?oc=5","date":"2024-04-08","type":"pipeline","source":"Built In","summary":"21 Atlanta Biotech Companies Making Waves in the Life Sciences Sector - Built In","headline":"21 Atlanta Biotech Companies Making Waves in the Life Sciences Sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNMm1jci1aRF9pXzVma2ZzZGdOVlpWUFZlWXJjXzZzY3V2LUR2WXRfeHROeEdFNWxhMkVNbWp0QUx2d3o0bmZRMml2ajRxZHNienhmV1dURzJpc2tKTmcyOXJZQ2o3RnFEQ0h3OVlmVThiVEtCMWVKV2NoTzVqRGdzRkQzY1oweDZGcUI0ZWFXSQ?oc=5","date":"2022-12-14","type":"trial","source":"AlphaSense","summary":"300+ transcripts from JPM's 39th Annual Healthcare Conference - AlphaSense","headline":"300+ transcripts from JPM's 39th Annual Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQRUJaYy1YeHFVTmFTZHVRRExHMmttY3JVWlJfbzJMNEwtU1MxZ181ck15Yzl1Zng5X1BENEpkbWQ2T0Q3bkc2cUFqVnAyLU9pdl9tQlcyTktCcWNUZDltR2NJZ2NKUnhEUkJpMW1ZUXNLbUg5M2lLMnM3Mks5ZldTRE00T1VoY3luVmp4TDRBbUQydnJOUEE5Z21pd2g3cDRONVNuYlkzVkJGU3FETUhnR25JZjNKZw?oc=5","date":"2021-04-16","type":"pipeline","source":"Nasdaq","summary":"Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual Meeting - Nasdaq","headline":"Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOS3plU1k4RGVNS2pSRnBSQmdmZXpXcUNqdWdPUzRMTEE2bEl4bHozVHdPY0pxcFc1RURwMHluZ0ZnVTVMM1doR3FwTU5IekhqOVpmY29UblhTNWZjX01jN21jQ0FneDE5M1h5Nktsdm4xVzI4WXdXdzhsQ043VTltVFZhY0hQY1NYWG1hY3hlLU9ZeHlxa0JmT3k1RE82YWlBQnZNeW92OHRkYVEzdEUtRVZ4UQ?oc=5","date":"2021-04-01","type":"pipeline","source":"Life Science Leader","summary":"What Advice Do You Have For Someone Aspiring To Become A Biopharma CEO? - Life Science Leader","headline":"What Advice Do You Have For Someone Aspiring To Become A Biopharma CEO?","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}